Mahtab Tavasoli Bio

Dr. Mahtab Tavasoli is a biomedical scientist specializing in lipid metabolism, neuromuscular disease, and gene therapy development. She earned her PhD in Medicine from the University of Alberta and completed her postdoctoral fellowship at Harvard Medical School, where she advanced research in lipid biology, mitochondrial dysfunction, and neurophysiology.

Dr. Tavasoli has played a central role in defining the scientific foundation for CHKB-associated muscular dystrophy therapeutics. During her work at the Atlantic Research Centre and Department of Pharmacology at Dalhousie University, she pioneered lipidomic, mitochondrial, and translational frameworks that now underpin multiple therapeutic development programs.

In 2026, Dr. Tavasoli joined McGill University as an Assistant Professor, where she leads an independent research program focused on how lipid dysregulation drives neuromuscular and neurodegenerative disease. Her laboratory integrates gene therapy, lipidomics, and mechanistic biology to advance therapies for rare metabolic disorders.

As a co-founder and Principle Research Scientist of HaliGene, Dr. Tavasoli directs the biological strategy underlying the company’s gene therapy pipeline, including first-in-class approaches for CHKB-associated muscular dystrophy and related ultra-rare disorders.